Nazione: Svizzera
Lingua: italiano
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
arnica montana e floribus sicc. Glückselig D2 (HAB 54c), aurum chloratum (HAB) D5 (HAB 5a), kaolinum ponderosum spag. Glückselig D2 (HAB, SV, 54b), calcium phosphoricum (HAB) D8 (HAB 6,8a), convallaria majalis ex herba rec. Glückselig D3 (HAB 54c), cuprum sulfuricum (HAB) D4 (HAB 5a), digitalis purpurea e folia rec. Glückselig D4 (HAB 54c), hydrargyrum bichloratum spag. Glückselig D6 (HAB 54b), stibium sulfuratum nigrum (HAB) D8 (HAB 6,8a), kalium hydrogentartraticum spag. Glückselig D2 (HAB, SV, 54b), sulfur (HAB) D7 (HAB 6,8a)
Apotheke zur Eiche AG
arnica montana e floribus sicc. Glückselig D2 (HAB 54c), aurum chloratum (HAB) D5 (HAB 5a), kaolinum ponderosum spag. Glückselig D2 (HAB, SV, 54b), calcium phosphoricum (HAB) D8 (HAB 6,8a), convallaria majalis ex herba rec. Glückselig D3 (HAB 54c), cuprum sulfuricum (HAB) D4 (HAB 5a), digitalis purpurea e folia rec. Glückselig D4 (HAB 54c), hydrargyrum bichloratum spag. Glückselig D6 (HAB 54b), stibium sulfuratum nigrum (HAB) D8 (HAB 6,8a), kalium hydrogentartraticum spag. Glückselig D2 (HAB, SV, 54b), sulfur (HAB) D7 (HAB 6,8a)
Gocce per uso orale
arnica montana e floribus siccatis Glückselig D2 (HAB 54c) 0.06 ml, aurum chloratum (HAB) D5 (HAB 5a) 0.07 ml, kaolinum ponderosum spag. Glückselig D2 (HAB, SV, 54b) 0.10 ml, calcium phosphoricum (HAB) D8 (HAB 6,8a) 0.25 ml, convallaria majalis ex herba rec. Glückselig D3 (HAB 54c) 0.06 ml, cuprum sulfuricum (HAB) D4 (HAB 5a) 0.10 ml, digitalis purpurea e folia rec. Glückselig D4 (HAB 54c) 0.06 ml, hydrargyrum bichloratum spag. Glückselig D6 (HAB 54b) 0.06 ml, stibium sulfuratum nigrum (HAB) D8 (HAB 6,8a) 0.07 ml, kalium hydrogentartraticum spag. Glückselig D2 (HAB, SV, 54b) 0.06 ml, sulfur (HAB) D7 (HAB 6,8a) 0.04 ml, ethanolum 96 per centum 0.29 ml, aqua purificata, ethanolum 20 per centum 0.07 ml, ad solutionem pro 1 ml, corresp. 36 guttae, corresp. ethanolum 29 % V/V.
D
Farmaci Omeopatici
Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)
zugelassen
2010-11-05